Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): a double-blind placebo-controlled randomized clinical trial

被引：0
|
作者：
Hasan Mirzazadeh [1 ]
Younes Ghaeminia [2 ]
Amin Mohamad Niaei [3 ]
Mohammadsadegh Kamran [4 ]
Leila Razeghian Jahromi [1 ]
Reza Moshfeghinia [1 ]
机构：
[1] Shiraz University of Medical Sciences,Research Center for Psychiatry and Behavior Science
[2] Shiraz University of Medical Sciences,School of Medicine
[3] Lorestan University of Medical Sciences,Student Research Committee
[4] Fasa University of Medical Sciences,Student Research Committee
[5] Shiraz University of Medical Science,Student’s research committee
[6] Shiraz University of Medical Sciences,Substance Abuse Research Center
来源：
BMC Psychiatry | / 25卷 / 1期
关键词：
Memantine; Escitalopram; Obsessive-Compulsive Disorder (OCD); Executive function; Augmentation therapy;
D O I：
10.1186/s12888-025-06856-7
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial
    Sanaz Askari
    Saba Mokhtari
    Seyed Vahid Shariat
    Behnam Shariati
    Masoomeh Yarahmadi
    Mohammadreza Shalbafan
    BMC Psychiatry, 22
  • [2] Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive- compulsive disorder: A double-blind placebo-controlled, randomized clinical trial
    Askari, Sanaz
    Mokhtari, Saba
    Shariat, Seyed Vahid
    Shariati, Behnam
    Yarahmadi, Masoomeh
    Shalbafan, Mohammadreza
    BMC PSYCHIATRY, 2022, 22 (01)
  • [3] Topiramate augmentation in refractory obsessive-compulsive disorder: A randomized, double-blind, placebo-controlled trial
    Afshar, Hamid
    Akuchekian, Shahla
    Mahaky, Behzad
    Zarean, Elham
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (10): : 976 - 981
  • [4] Pregabalin augmentation for resistant obsessive-compulsive disorder: a double-blind placebo-controlled clinical trial
    Mowla, Arash
    Ghaedsharaf, Mehrnoosh
    CNS SPECTRUMS, 2020, 25 (04) : 552 - 556
  • [5] Memantine add-on in moderate to severe obsessive-compulsive disorder: Randomized double-blind placebo-controlled study
    Ghaleiha, Ali
    Entezari, Neda
    Modabbernia, Amirhossein
    Najand, Babak
    Askari, Neda
    Tabrizi, Mina
    Ashrafi, Mandana
    Hajiaghaee, Reza
    Akhondzadeh, Shahin
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (02) : 175 - 180
  • [6] Memantine as an Adjuvant Treatment for Obsessive Compulsive Symptoms in Manic Phase of Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
    Sahraian, Ali
    Jahromi, Leila Razeghian
    Ghanizadeh, Ahmad
    Mowla, Arash
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2017, 37 (02) : 246 - 249
  • [7] In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)
    Mohammad Haghighi
    Leila Jahangard
    Hamid Mohammad-Beigi
    Hafez Bajoghli
    Hassan Hafezian
    Alireza Rahimi
    Hamid Afshar
    Edith Holsboer-Trachsler
    Serge Brand
    Psychopharmacology, 2013, 228 : 633 - 640
  • [8] Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial
    Farnia, Vahid
    Gharehbaghi, Haniyeh
    Alikhani, Mostafa
    Almasi, Afshin
    Golshani, Sanobar
    Tatari, Faeze
    Davarinejad, Omran
    Salemi, Safora
    Bahmani, Dena Sadeghi
    Holsboer-Trachsler, Edith
    Brand, Serge
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 104 : 137 - 143
  • [9] In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)
    Haghighi, Mohammad
    Jahangard, Leila
    Mohammad-Beigi, Hamid
    Bajoghli, Hafez
    Hafezian, Hassan
    Rahimi, Alireza
    Afshar, Hamid
    Holsboer-Trachsler, Edith
    Brand, Serge
    PSYCHOPHARMACOLOGY, 2013, 228 (04) : 633 - 640
  • [10] Memantine for Refractory Obsessive-Compulsive Disorder: Protocol for a Pragmatic, Double-blind, Randomized, Parallel-Group, Placebo-Controlled, Monocenter Trial
    Maraone, Annalisa
    Trebbastoni, Alessandro
    Di Vita, Antonella
    D'Antonio, Fabrizia
    De Lena, Carlo
    Pasquini, Massimo
    JMIR RESEARCH PROTOCOLS, 2023, 12
12345